483Feb 4, 2022
483 Document: UCB Pharma S.A.


On Feb 04, 2022, the FDA inspected UCB Pharma S.A.'s Braine-l'alleud site. Explore the inspectional observations.


On Feb 04, 2022, the FDA inspected UCB Pharma S.A.'s Braine-l'alleud site. Explore the inspectional observations.